Delivery Order SPE2DE21D7009-SPE2D626F04B2
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,825.75 delivery order for pain management medical devices under contract 4570282591. The award, issued on November 28, 2025, with an ultimate completion date of December 5, 2025, utilizes a fixed-price contract with economic price adjustment pricing structure. The contract is not designated for any small business set-aside and will be performed in Valencia, California. This delivery order...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,798.00 on November 28, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 5, 2025 and will be performed in Valencia, California. The award was issued by the Medical Supply Chain, a Defense-related procurement entity within the federal government, with no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,834.00 on November 28, 2025, for pain management medical devices and services. The delivery order, which is fixed price with economic price adjustment provisions, has an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. This award represents a child delivery order issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $42,456.67 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment provisions falls under the larger Defense Logistics Agency Troop Support Medical indefinite delivery contract (SPE2DE) valued at $83.1 million and running through August 16, 2026. The award carries no small business set-aside...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $2,683.75 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 5, 2025. The contract employs fixed-price pricing with economic price adjustment and is issued without a small business set-aside. The work will be performed in Valencia, California, under the Defense Logistics Agency's Medical Supply Chain procurement entity....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F04B2Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE) valued at $83.1 million and extending through August 16, 2026. The award was issued without set-aside designations, allowing Boston Scientific Neuromodulation to compete unrestricted in the federal marketplace. Work will be performed at the company's facility in Valencia, California. The contract supports the Defense Logistics Agency's medical supply operations by delivering neuromodulation solutions and pain management technologies to military treatment facilities and Veterans Affairs medical centers nationwide. Boston Scientific Neuromodulation specializes in advanced non-opioid pain management technologies, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices, along with associated accessories and technical support. The company's focus on serving service members and veterans with chronic pain management resulting from traumatic injuries aligns with the Department of Defense's broader clinical objectives in reducing opioid dependency while improving pain outcomes across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 11/27/25 |